Cargando…

Why Did the FDA Approve These Advertisements?

Detalles Bibliográficos
Autor principal:	Oaks, David
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Correspondence and Other Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1388066/ https://www.ncbi.nlm.nih.gov/pubmed/16492081 http://dx.doi.org/10.1371/journal.pmed.0030117

Ejemplares similares

Consumer Advertising Can Be Misleading
por: Rickels, Karl
Publicado: (2006)

Why Are There So Few FDA-Approved Therapeutics for Wound Healing?
por: Chen, Mei, et al.
Publicado: (2023)

Questionable Advertising of Psychotropic Medications and Disease Mongering
por: Lacasse, Jeffrey R, et al.
Publicado: (2006)

Correction/Clarification about FDA Review Documents
por: Turner, Erick
Publicado: (2005)

Why the Better Element of the Dental Profession Does Not Approve of Advertising
por: Loege, E. Ballard
Publicado: (1900)

Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
por: Khan, Abdul Moiz, et al.
Publicado: (2023)

Celebrating breakthrough in dental diagnostics: FDA approval of an AI model for diagnosis of periodontal diseases: A correspondence
por: Khan, Ayesha, et al.
Publicado: (2023)

Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence
por: Abbasi, Haleema Qayyum, et al.
Publicado: (2023)

Did Glycopeptide Use in Animals Result in Hospital Infections of VRE?
por: Mudd, Anthony
Publicado: (2005)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
por: Mahajan, Rajiv
Publicado: (2009)

Recently FDA-approved drug: A new hope for vitiligo patients?
por: Siddiq, Mohammad Arham, et al.
Publicado: (2022)

Medical Advertising
Publicado: (1880)

Professional Advertisements
Publicado: (1878)

Professional Advertisements
Publicado: (1878)

Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
por: Rodriguez, Ismael, et al.
Publicado: (2023)

Why We Whistleblowers Are Passionate in Our Convictions
por: Kruszewski, Stefan P
Publicado: (2005)

FDA approves Ruxolitinib (Opzelura) for Vitiligo Therapy: A breakthrough in the field of dermatology
por: Sheikh, Ayesha, et al.
Publicado: (2022)

Advertisements in Medical Journals
por: Mukherjee, I. B.
Publicado: (1950)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Why did the Japanese Government take so long to approve the intrauterine contraceptive device?
por: Homei, Aya
Publicado: (2018)

Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia
por: Sachdeva, Mamta, et al.
Publicado: (2015)

Olumniant (Baricitinib) oral tablets: An insight into FDA-approved systemic treatment for Alopecia Areata
por: Ali, Eman, et al.
Publicado: (2022)

Advertising a Contribution Scheme
por: Lamb, S. R.
Publicado: (1922)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Medical Advertisements through Dispensaries, Etc.
Publicado: (1877)

Advertising in Medical College Announcements and in Newspapers
Publicado: (1880)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

The FDA-Approved Drug Pyrvinium Selectively Targets ER(+) Breast Cancer Cells with High INPP4B Expression
por: Rodgers, Samuel J., et al.
Publicado: (2022)

Why Do Doctors Not Advertise?
Publicado: (1893)

Current FDA-Approved Therapies for High-Grade Malignant Gliomas
por: Fisher, Jacob P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_24nfiv8vs4bjmcrfign3e00r3h